TRex Bio, Inc. (TRXB) stock analysis
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$14.10−0.15 (-1.05%)
Close on Nov 12, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for TRex Bio.
See a number that looks wrong?